Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
12 studies found for:    LAM | Open Studies | NIH, U.S. Fed
Show Display Options
RSS Create an RSS feed from your search for:
LAM | Open Studies | NIH, U.S. Fed
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC
Condition: Lymphangioleiomyomatosis (LAM)
Intervention: Drug: Celecoxib
2 Recruiting Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
Condition: Lymphangioleiomyomatosis
Interventions: Drug: albuterol inhaler;   Procedure: PFT;   Drug: albuterol nebulizer
3 Recruiting Study of the Disease Process of Lymphangioleiomyomatosis
Conditions: Lung Disease;   Pneumothorax;   Tuberous Sclerosis
Intervention:
4 Recruiting Safety and Durability of Sirolimus for Treatment of LAM
Condition: Lymphangioleiomyomatosis
Interventions: Drug: Sirolimus;   Drug: Everolimus
5 Recruiting Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis
Condition: Pulmonary Lymphangioleiomyomatosis
Intervention: Drug: saracatinib
6 Recruiting VA MERIT: A Comparative Efficacy Study: Treatment of Non-Healing Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcer
Interventions: Device: SECONDARY dressing gauze and tape;   Procedure: debridement, irrigation;   Device: Dermagraft™;   Device: Oasis™
7 Recruiting Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations
Conditions: Metastatic Transitional Cell Carcinoma;   Metastatic Urothelial Carcinoma;   Recurrent Bladder Carcinoma;   Stage III Bladder Urothelial Carcinoma;   Stage IV Bladder Urothelial Carcinoma;   TSC1 Gene Mutation;   TSC2 Gene Mutation
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Sapanisertib
8 Recruiting Deuterated Phenanthrene Tetraol in Smokers Who Are at High Risk For Lung Cancer
Conditions: Lung Cancer;   Squamous Lung Dysplasia;   Tobacco Use Disorder
Interventions: Radiation: deuterated phenanthrene tetraol;   Other: pharmacological study;   Other: laboratory biomarker analysis
9 Recruiting Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
Conditions: Colorectal Adenocarcinoma;   KRAS wt Allele;   NRAS wt Allele;   Stage IV Colorectal Cancer;   Stage IVA Colorectal Cancer;   Stage IVB Colorectal Cancer
Interventions: Biological: Bevacizumab;   Biological: Cetuximab;   Drug: Irinotecan;   Other: Laboratory Biomarker Analysis;   Other: Placebo
10 Recruiting International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)
Conditions: Cardiovascular Diseases;   Coronary Disease;   Coronary Artery Disease;   Heart Diseases;   Myocardial Ischemia
Interventions: Procedure: cardiac catheterization;   Procedure: coronary artery bypass graft surgery;   Procedure: percutaneous coronary intervention;   Behavioral: Lifestyle;   Drug: Medication
11 Not yet recruiting The International Diabetes Closed Loop (iDCL) Trial: Main Protocol
Condition: Type1 Diabetes Mellitus
Interventions: Device: Artificial Pancreas;   Other: Sensor Augmented Therapy;   Device: continuous glucose monitor (CGM)
12 Recruiting International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol
Condition: Diabetes Mellitus, Type 1
Intervention: Device: Artificial Pancreas

Study has passed its completion date and status has not been verified in more than two years.